Area of research
Oncology · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Epigenetics and DNA Methylation, Cancer Genomics and Diagnostics, and Radiopharmaceutical Chemistry and Applications.
Association between pathologic response and survival after neoadjuvant therapy in lung cancer
NRF2 Activation Promotes Aggressive Lung Cancer and Associates with Poor Clinical Outcomes
Compartmental Analysis of T-cell Clonal Dynamics as a Function of Pathologic Response to Neoadjuvant PD-1 Blockade in Resectable Non–Small Cell Lung Cancer
DNA Methylation Markers for Breast Cancer Detection in the Developing World
Chemotherapy induces enrichment of CD47 <sup>+</sup> /CD73 <sup>+</sup> /PDL1 <sup>+</sup> immune evasive triple-negative breast cancer cells
Dynamics of Tumor and Immune Responses during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
Peptide-based PET quantifies target engagement of PD-L1 therapeutics
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
Long Interspersed Element-1 Protein Expression Is a Hallmark of Many Human Cancers
Activation of diverse signalling pathways by oncogenic PIK3CA mutations
TBCRC 008: Early Change in <sup>18</sup>F-FDG Uptake on PET Predicts Response to Preoperative Systemic Therapy in Human Epidermal Growth Factor Receptor 2–Negative Primary Operable Breast Cancer
Collective Invasion in Breast Cancer Requires a Conserved Basal Epithelial Program
Transcription factor NRF2 regulates miR-1 and miR-206 to drive tumorigenesis
Biomarkers for detection and prognosis of breast cancer identified by a functional hypermethylome screen